Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 7.3T | 7.1T | 7.3T | 6.5T |
Cost of revenue | 4.4T | 3.5T | 3.6T | 3.2T |
Gross profit | 2.9T | 3.6T | 3.7T | 3.3T |
Operating expense | ||||
Research & development | 1.8T | 1.6T | 1.6T | 1.6T |
Selling general and admin | 944.0B | 844.0B | 754.4B | 686.8B |
Other operating expenses | — | — | -10.5B | -13.3B |
Operating income | -127.6B | 767.8B | 1.0T | 689.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 36.2B | 19.1B | 18.1B | 21.9B |
Other income expense | 93.3B | 37.1B | -315.3B | 34.3B |
Pretax income | -70.5B | 785.9B | 846.8B | 702.0B |
Tax provision | -794.4B | 117.2B | 399.1B | -25.7B |
Net income | 830.6B | 675.4B | 459.1B | 734.4B |
Basic EPS | 0.5 | 0.4 | 0.3 | 0.5 |
Diluted EPS | 0.5 | 0.4 | 0.3 | 0.5 |
Basic average shares | 1.5T | 1.5T | 1.5T | 1.5T |
Diluted average shares | 1.6T | 1.5T | 1.6T | 1.6T |
EBITDA | 686.8B | 1.5T | 1.6T | 1.5T |
Net income from continuing op. | 731.6B | 675.4B | 459.1B | 734.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |